Evidence map›Paper›PMID 40352886›Full record

ArticleIndian journal of nephrology

Risk Factors for Mortality Among Patients on Hemodialysis in India: A Case-Control Study.

Suresh Sankarasubbaiyan, Carol A Pollock, Urmila Anandh, Savitha Kasiviswanathan, Kamal D Shah

Abstract read
In one paragraph

Article in Indian journal of nephrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suresh SankarasubbaiyanNephroPlus Dialysis Centers, Hyderabad, Telangana, India.
Carol A PollockDepartment of Medicine, Northern Clinical School, Kolling Institute of Medical Research, The University of Sydney, Australia.
Urmila AnandhDepartment of Nephrology, Amrita Hospitals, Faridabad, Delhi, India.
Savitha KasiviswanathanNephroPlus Dialysis Centers, Hyderabad, Telangana, India.
Kamal D ShahNephroPlus Dialysis Centers, Hyderabad, Telangana, India.ORCID https://orcid.org/0000-0002-4642-7136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mortality in hemodialysis (HD) exceeds that of many solid organ cancers, despite advancements in care. This study was conducted to understand mortality in a large dialysis network of Indian HD patients and attempt to elucidate risk factors for mortality. Materials and Methods: We performed a case-control study of deaths among patients undergoing HD across 203 centers in India from January 1 to March 31, 2021 with an age-matched control of survivors. We reviewed demographic, dialysis, clinical, and socioeconomic factors. Results: Out of 17,659 patients on dialysis, 554 cases (non-survivors) and 623 age-matched controls (survivors) patients were followed up. The mean age was 54.9 ± 13.8 years, 70.5% (391) of them were males. Gender, BMI, dialysis frequency, HD vintage time, history of diabetes, and heart failure were similar between non-survivors and survivors. Lower education level, payment under public insurance, dialysis facility under a public-private partnership, vascular access via catheter, hemoglobin <8 g/dL levels, serum albumin <3.5 g/dL were significantly higher, hospitalizations in 3 months prior to death were more frequent among non-survivors. Conclusion: Factors including Hb <8 g/dL, temporary catheter, serum albumin less <3.5 g/dL, lower educational status, and dialysis under public insurance are associated with poorer survival in our population. Our findings have implications for designing interventions needed to improve outcomes for evolving policy and public-payer systems.

Indexed as

Chronic kidney diseaseEnd-stage renal diseaseHemodialysisMortalityRisk factors

Identifiers

PMID40352886
PMCPMC12065611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.